Anger over Shell $4.3bn profits; Rolls-Royce earnings soar 50%
How did your country report this? Share your view in the comments.
Diverging Reports Breakdown
Rolls-Royce shares soar to new record high; anger over Shell $4.3bn profits – business live
The jet engine manufacturer was valued at £83bn yesterday evening, so another 10% gain puts its valuation at more than £92bn. Its market value has almost doubled over the course of 2025 – an astonishing run for a company that faced an existential threat during the coronavirus pandemic. The company also received a recent boost from the UK government’s decision to choose it to deliver the first small modular nuclear reactors (SMRs)
Please turn on JavaScript to use this feature
2m ago 08.31 BST Rolls-Royce valuation soars to record £90bn as shares gain 10%
Rolls-Royce’s share price has soared by 10.5% in early trading this morning, to a new record high – with the company’s valuation breaking the £90bn mark for the first time.
The jet engine manufacturer was valued at £83bn yesterday evening, so another 10% gain puts its valuation at more than £92bn. Its market value has almost doubled over the course of 2025 – an astonishing run for a company that faced an existential threat during the coronavirus pandemic.
The company’s turnaround has so far been a triumph for chief executive Tufan Erginbilgic, who ruffled feathers on taking over the business in 2023 by saying it was on a “burning platform”.
Since then Erginbilgic has cut costs, and pushed customers to pay more for its products through renegotiating contracts for maintaining jet engines that go on widebody planes such as the Airbus A350 and Boeing’s 787.
The company also received a recent boost from the UK government’s decision to choose it to deliver the first small modular nuclear reactors (SMRs) – factory-produced nuclear power stations that aim to cut costs.
Rolls-Royce said the SMR business – which it hopes could eventually be bigger than the existing revenues – should be “profitable and free cash flow positive by 2030” – ahead of delivery of the first SMRs a couple of years later.